POST 7th_IOIF
​​​> ATTENDEES
​​> INVESTORS
​​​> PRESENTERS
> SPONSORS
​​> SUPPORTERS

​> ABOUT ​LAST YEAR
​PARTICIPATING COMPANIES IN 2021 INCLUDE:
3B Future Health Fund
4C Biomed Services Ltd.
6 Dimensions Capital
AbbVie Deutschland GmbH Co. KG
AbbVie Ventures
AbbVie, Inc.
Advent France Biotechnology
Aescuvest International
Agenus, Inc.
Aisling Capital LLC
Aleta Biotherapeutics
Allele Capital Partners
Alliance for Cancer Gene Therapy
Alloy Therapeutics, Inc.
Ally Bridge Group
Alphageneron Pharmaceuticals, Inc.
Alphamab Oncology
ALSA Ventures
Amplitude Ventures
Angel Investor
APEIRON Biologics AG
Apogenix AG
Aqua Partners LLC
ARB Trading Group
ARCH Venture Partners
Ashvattha Therapeutics
Asklepios Advisors
Astellas Pharma, Inc.
AstraZeneca
ATEM Capital
Atlas Advisors LLC
AVANTECA Partners AG
Avestria Ventures
Avoro Capital Advisors
B'IMPRESS - impressive communication in eHealth & Biotech
Banca del Cereesio
BB Pureos Bioventures
BeiGene Ltd.
BerGenBio ASA
BERNINA BioInvest Ltd.
Bexion Pharmaceuticals, Inc.
Bio Med Gene Ventures
BioCurate Pty Ltd
BioGeneration Ventures
BioMedPartners AG
Bionova Capital SCR SA
BioNTech SE
Bioqube Ventures
BioSense Global LLC
BIOSTART Consulting GmbH
BlueYard Capital
Boehringer Ingelheim International GmbH
Bootstrap Europe SCSP
Boston Financial LLC
Bpifrance
Bradley Woods & Co. Ltd
Breslin AG
Brookline Capital Markets
BVF Partners, L.P.
Carisma Therapeutics Inc.
Catalytic Impact Foundation
CBC Group (C-Bridge Capital)
CBT Advisors
Cederberg GmbH
Cello Health BioConsulting
Claris Ventures
Clavis Capital Ltd.
Convergence Partners
Cowen, Inc.
Cytovia Therapeutics, Inc.
Dana-Farber Cancer Institute
Dartmouth College
Domain Therapeutics SA
Easton Capital Investment Group
Eli Lilly and Company
eTheRNA immunotherapies NV
Exactis Innovation
EXUMA Biotechnology
F-star Therapeutics Inc.
F. Hoffmann-La Roche Ltd.
Ferghana Partners LLP
Fortunatus Capital
Forty51 ventures
FreeMind Group
FutuRx Ltd.
GCF Family Office
Geneos Therapeutics
Generation Life Science Fund
Genesys Capital
GlaxoSmithKline
GLSV GmbH
GO CAPITAL
Gracell Biotechnologies
GreenSky Capital
Gritstone Oncology, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Hansoh Bio
Harpoon Therapeutics, Inc.
HBM Partners AG
Health Innovation Capital
HealthCap
High-Tech Gründerfonds Management GmbH
HitchinRock Advisors Limited
Howard J. Fingert MD Consulting
i2020 Accelerator
ICF Consult Switzerland
ICG Capital
IGM Biosciences, Inc.
Illumina Accelerator
Illumina Ventures
Imagia
Immuneering Corporation
IMV Inc.
Indaco Venture Partners SGR SpA
Independent
InflaRx GmbH
INKEF Capital BV
Inveready
IO Biotech ApS
Iovance Biotherapeutics, Inc.
IPF Partners
Ipsen
Jalon Therapeutics
Johnson & Johnson Innovation – JJDC, Inc.
Johnson & Johnson Innovation LLC
Kairos Venture Investments, LLC
Kreos Capital
Kurma Partners
L.E.K. Consulting
Lancea LLP
Landmark Angels, Inc.
Lazard Ltd.
LBBW Venture Capital
LifeLink Ventures
LifeSci Advisors
Lilly Asia Ventures
Locust Walk
Loncar Investments, LLC
Lumira Ventures
Lundbeckfonden Ventures / Lundbeckfonden Emerge
LYFE Capital
M Ventures
Macrophage Pharma Ltd.
Marker Therapeutics, Inc.
Mass General Brigham Ventures
MD Anderson Cancer Center
MedinCell S.A.
Mediqventures
MedPro Investors
Mehta Partners
Merck KGaA
Moore Venture Partners
MPM Capital, Inc.
MRL Ventures Fund
MSD
MSQ Ventures
Murdock Capital Partners Corp.
Nanobiotix Corp.
Negma Group Ltd
New York Academy of Sciences
Nextech Invest AG
Novartis Venture Fund
Novo Holdings A/S
NOXXON Pharma NV
NRW.Bank
NxR Biotechnologies GmbH
Omega Fund Management, LLC
ONCURIOUS NV
Oost NL
ORI Capital Limited
Orion Biotechnology Canada Ltd.
OSE Immunotherapeutics
Panacea Venture
Panakès Partners SGR SpA
Pfizer Ventures
PharmAbcine, Inc.
PharmaVentures Ltd.
Phosplatin Therapeutics Inc.
Photon Fund
Pivotal bioVenture Partners
Portugal Ventures, SA
Prevail Partners, LLC
Prime Movers Lab
Qiming Venture Partners
QLSF Biotherapeutics, Inc.
Quan Capital
RBV Capital
Real Endpoints LLC
Redalpine Venture Partners AG
Refuge Biotechnologies, Inc.
Remiges Ventures
Roche Diagnostics
Roivant Sciences GmbH
Rosetta Capital Ltd
Rubius Therapeutics, Inc.
Sand Hill Angels
SBI JI Innovation Advisory Ltd.
Schwarz Financial Communication
Seroba Life Sciences
Shadow Lake Group Inc.
Shaw Strategic Capital LLC
Silicon Valley Bank
SIWA Therapeutics, Inc
Sofinnova Partners
SOTIO a.s.
Stanphyl Capital
SternAegis Ventures
Stifel Financial Corp.
STipe Therapeutics
Strategic Transactions Advisory AG
Sweetwater Capital Partners
Taiho Ventures, LLC
TargImmune Therapeutics AG
The Leukemia & Lymphoma Society
The Mark Foundation for Cancer Research
Thermopharma
Treos Bio Ltd.
Triumvira Immunologics, Inc.
TVM Life Science Management GmbH
Ultimovacs ASA
Ultreum Life Science DMCC
Valor Management S.A.
VAXIMM
VCapital Management Co., LLC
VCN Biosciences SL
Ventac Capital
Versant Ventures
Vesalius Biocapital
VI Partners AG
Vida Ventures, LLC
Vista Point Capital LLC
VIV Capital
Vogel BioC
Wellington Partners
Wille Finance AG
Windeye Partners Inc.
XOventure GmbH
YUNION Healthcare Ventures​
​Last Updated on: 24th of May, 2021